Risk of serious falls associated with oxybutynin and tolterodine: A population based study

Journal of Urology

Volumn 186, Issue 4, 2011, Pages 1340-1344

  Gomes, Tara ^a,b   Juurlink, David N ^a,b,c   Ho, Joanne M W ^c   Schneeweiss, Sebastian ^f   Mamdani, Muhammad M ^{a,b,c,d,e,f,g}  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Department of Medicine ^*  (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f HARVARD MEDICAL SCHOOL   (United States)

^g KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

drug toxicity; pharmacoepidemiology; urinary incontinence

Indexed keywords

OXYBUTYNIN; TOLTERODINE;

AGED; ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; DELIRIUM; DISEASE ASSOCIATION; FALL RISK; FALL RISK ASSESSMENT; FALLING; FEMALE; FRACTURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; URINE INCONTINENCE;

ACCIDENTAL FALLS; AGED; BENZHYDRYL COMPOUNDS; CRESOLS; EMERGENCY SERVICE, HOSPITAL; HOSPITALIZATION; HUMANS; MANDELIC ACIDS; MUSCARINIC ANTAGONISTS; PHENYLPROPANOLAMINE; RISK FACTORS; URINARY INCONTINENCE, URGE;

EID: 80052729402     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.05.077     Document Type: Article

References (30)

1. P. Abrams, L. Cardozo, and M. Fall The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society Urology 61 2003 37
2. C. Liu, and G.R. Andrews Prevalence and incidence of urinary incontinence in the elderly: a longitudinal study in South Australia Chin Med J (Engl) 115 2002 119
3. D. Thom Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type J Am Geriatr Soc 46 1998 473
4. J.S. Brown, D. Grady, and J.G. Ouslander Prevalence of urinary incontinence and associated risk factors in postmenopausal women Heart & Estrogen/Progestin Replacement Study (HERS) Research Group Obstet Gynecol 94 1999 66
5. C.H. van derVaart, J.G. van derBom, and J.R. de Leeuw The contribution of hysterectomy to the occurrence of urge and stress urinary incontinence symptoms BJOG 109 2002 149
6. C. Temml, G. Haidinger, and J. Schmidbauer Urinary incontinence in both sexes: prevalence rates and impact on quality of life and sexual life Neurourol Urodyn 19 2000 259
7. E. Dugan, S.J. Cohen, and D.R. Bland The association of depressive symptoms and urinary incontinence among older adults J Am Geriatr Soc 48 2000 413
8. J.F. Wyman, S.W. Harkins, and J.A. Fantl Psychosocial impact of urinary incontinence in the community-dwelling population J Am Geriatr Soc 38 1990 282
9. G. Nabi, J.D. Cody, and G. Ellis Anticholinergic drugs versus placebo for overactive bladder syndrome in adults Cochrane Database Syst Rev 4 2006 CD003781
10. J. Hay-Smith, P. Herbison, and G. Ellis Which anticholinergic drug for overactive bladder symptoms in adults Cochrane Database Syst Rev 3 2005 CD005429
11. P. Abrams, K.E. Andersson, and J.J. Buccafusco Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder Br J Pharmacol 148 2006 565
12. G.G. Kay, M.B. Abou-Donia, and W.S. Messer Jr Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients J Am Geriatr Soc 53 2005 2195
13. R. Scheife, and M. Takeda Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly Clin Ther 27 2005 144
14. A. Todorova, B. Vonderheid-Guth, and W. Dimpfel Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system J Clin Pharmacol 41 2001 636
15. K.W. Herberg Everyday life safety and safety while driving under treatment with incontinence drugs: new examinations regarding safety of anticholinergic drugs Med Welt 50 1999 217
16. I.R. Katz, L.P. Sands, and W. Bilker Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride J Am Geriatr Soc 46 1998 8
17. M. Lawrence, D.R. Guay, and S.R. Benson Immediate-release oxybutynin versus tolterodine in detrusor overactivity: a population analysis Pharmacotherapy 20 2000 470
18. D. Aizenberg, M. Sigler, and A. Weizman Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study Int Psychogeriatr 14 2002 307
19. S. Berdot, M. Bertrand, and J.F. Dartigues Inappropriate medication use and risk of fallsa prospective study in a large community-dwelling elderly cohort BMC Geriatr 9 2009 30
20. D.N. Juurlink, C. Preyra, and R. Croxford Canadian Institute for Health Information Discharge Abstract Database: A Validation Study 2006 Institute for Clinical Evaluative Sciences Toronto
21. J.L. Williams, and W. Young A summary of studies on the quality of health care administrative databases in Canada V. Goel, J.L. Williams, G.M. Anderson, Patterns of Health Care in Ontario, The ICES Practice Atlas 2nd ed. 1996 Canadian Medical Association Ottawa 339 345
22. S. Schneeweiss, J.A. Rassen, and R.J. Glynn High-dimensional propensity score adjustment in studies of treatment effects using health care claims data Epidemiology 20 2009 512
23. M.E. Charlson, P. Pompei, and K.L. Ales A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373
24. M. Mamdani, K. Sykora, and P. Li Reader's guide to critical appraisal of cohort studies: 2 Assessing potential for confounding BMJ 330 2005 960
25. R.A. Appell Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis Urology 50 1997 90
26. A.M. MacLullich, A. Beaglehole, and R.J. Hall Delirium and long-term cognitive impairment Int Rev Psychiatry 21 2009 30
27. K. Rockwood Need we do so badly in managing delirium in elderly patients? Age Ageing 32 2003 473
28. M.G. Cole Persistent delirium in older hospital patients Curr Opin Psychiatry 23 2010 250
29. F.M. Chu, R.R. Dmochowski, and D.J. Lama Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trial Am J Obstet Gynecol 192 2005 1849
30. D.M. Fick, J.W. Cooper, and W.E. Wade Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts Arch Intern Med 163 2003 2716